This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thureen, P. J.
Right arrow Articles by Hall, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thureen, P. J.
Right arrow Articles by Hall, D. M.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 103 No. 3 March 1999, pp. 594-598

Once- Versus Twice-daily Gentamicin Dosing in Neonates >= 34 Weeks' Gestation: Cost-effectiveness Analyses

Received Jun 11, 1998; accepted Sep 3, 1998.

Patti J. ThureenDagger , Pamela D. Reiter*, Adrian Gresores§, Nancy M. Stolpman*, Kerry Kawato*, and Daniel M. HallDagger

From the Departments of * Pharmacy and Dagger  Pediatrics, Section of Neonatology, University of Colorado Health Sciences Center and Children's Hospital, Denver, Colorado; and § Magella Medical Associates, PA, Dallas, Texas.

Objectives.  To compare performance and cost analysis of two gentamicin regimens in infants >= 34 weeks' gestation requiring antibiotics for a 72-hour rule-out sepsis evaluation. A once-daily dosing (ODD) regimen of 4 mg/kg was compared with a standard twice-daily dosing (TDD) regimen of 2.5 mg/kg every 12 hours.

Setting and Design.  Infants at two university-affiliated Level III nurseries were prospectively temporally allocated to receive ODD (n = 27) or TDD (n = 28) as part of their 72-hour empirical antibiotic regimen. Performance of dosing regimens was based on target serum gentamicin concentrations (SGC) established prospectively as a peak of 5 to 10 µg/mL and a trough of <= 2 µg/mL. SGC were determined by fluorescence polarization immunoassay on day 3 of therapy. Cost data were obtained by distributing a questionnaire to 15 pediatric pharmacy practice sites. Inquiries were made regarding hospital cost of drug acquisition, drug supplies, drug preparation and administration, and serum concentration analysis. Performance and cost data were then used to do a cost-effectiveness analysis.

Results.  Mean peak concentrations were higher with ODD (7.9 ± 0.2 µg/mL) than TDD (6.7 ± 0.3 µg/mL). Half of the patients in the TDD group had trough concentrations >2 µg/mL, compared with none in the ODD group. Overall, 57% of the SGCs in the TDD group were outside the target concentration range versus 7% in the ODD group. Based on questionnaire results, a total 72-hour process cost of ODD versus TDD was compared for regimens with and without use of SGC analysis. If SGCs are obtained, more than 75% of the cost associated with gentamicin therapy is attributable to SGC analysis. Based on a cost-effectiveness analysis, ODD was the dominant dosing strategy in all categories analyzed.

Conclusions.  ODD of gentamicin at 4 mg/kg in neonates >= 34 weeks' gestation is the preferable treatment strategy based on: 1) significantly improved SGC performance compared with TDD; 2) elimination of the need for routine SGC collection in infants on short courses of therapy; and 3) significant antibiotic-associated hospital cost savings when compared with conventional therapy of TDD and SGC analysis.  Key words:  gentamicin, dosing, once daily, drug concentrations, peak, trough, cost-effectiveness, pharmacoeconomics, neonate.




This article has been cited by other articles:


Home page
 Pediatr. Rev.Home page
J. M. Olsson
Pharmacokinetics
Pediatr. Rev., October 1, 2007; 28(10): 397 - 398.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
L. S. Hale and C. R. Durham
A simple, weight-based, extended-interval gentamicin dosage protocol for neonates
Am. J. Health Syst. Pharm., August 1, 2005; 62(15): 1613 - 1616.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
E Nestaas, H-J Bangstad, L Sandvik, and K-O Wathne
Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2005; 90(4): F294 - f300.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
G. J. Locksmith, A. Chin, T. Vu, K. E. Shattuck, and G. D. V. Hankins
High Compared With Standard Gentamicin Dosing for Chorioamnionitis: A Comparison of Maternal and Fetal Serum Drug Levels
Obstet. Gynecol., March 1, 2005; 105(3): 473 - 479.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M English, S Mohammed, A Ross, S Ndirangu, G Kokwaro, F Shann, and K Marsh
A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants
Arch. Dis. Child., July 1, 2004; 89(7): 665 - 669.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. G. Contopoulos-Ioannidis, N. D. Giotis, D. V. Baliatsa, and J. P. A. Ioannidis
Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis
Pediatrics, July 1, 2004; 114(1): e111 - e118.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Bajaj and K Palmer
Gentamicin usage in newborns: an audit
Arch. Dis. Child., July 1, 2003; 88(7): 645 - 645.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Z. A. Dotan, R. Hana, D. Simon, D. Geva, R. A. Pfeffermann, and T. Ezri
The Effect of Vecuronium Is Enhanced by a Large Rather than a Modest Dose of Gentamicin as Compared with No Preoperative Gentamicin
Anesth. Analg., March 1, 2003; 96(3): 750 - 754.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. D. Stickland, C. M. J. Kirkpatrick, E. J. Begg, S. B. Duffull, S. J. Oddie, and B. A. Darlow
An extended interval dosing method for gentamicin in neonates
J. Antimicrob. Chemother., December 1, 2001; 48(6): 887 - 893.
[Abstract] [Full Text] [PDF]